Company: FCRS
Filing Date: 2025-09-26
Form Type: 424B4
Source: 0001213900-25-092098
Chunk: 86

Company: FutureCrest Acquisition Corp.
Filing Date: 2025-09-26
Form: 424B4
Chunk 86
---
 was determined by dividing the amount of cash contributed to the company by the number of founder shares issued. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 28,750,000 units if the underwriters’ over -allotmentoption is exercised in full, and therefore that such founder shares would represent 20% of the outstanding shares after this offering. Our public shareholders may incur material dilution due to such anti -dilutionadjustments that result in the issuance of Class A ordinary shares on a greater than one -to -onebasis upon conversion. Up to 937,500 of the founder shares will be surrendered for no consideration depending on the extent to which the underwriters’ over -allotmentoption is exercised. The founder shares will be worthless if we do not complete an initial business combination, except to the extent they receive liquidating distributions from assets outside of the trust account. In addition, our sponsor and Cantor Fitzgerald & Co., the representative of the underwriters, have committed to purchase an aggregate of 3,500,000 private placement warrants, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $2.00 per warrant, or $7,000,000 in the aggregate, in a private placement that will close simultaneously with the closing of this offering. Of those 3,500,000 private placement warrants, our sponsor has agreed to purchase 2,250,000 warrants and Cantor Fitzgerald & Co. has agreed to purchase 1,250,000 warrants. The private placement warrants will be worthless if we do not complete our initial business combination. The personal and financial interests of our officers and directors may influence their motivation in identifying and selecting a target business combination, completing an initial business combination and influencing the operation of the business following the initial business combination. This risk may become more acute as the end of the completion window nears, which is the deadline for our completion of an initial business combination. We may issue notes or other debt securities, or otherwise incur substantial debt, to complete a business combination, which may adversely affect our leverage and financial condition and thus negatively impact the value of our shareholders’ investment in us. Although we have no commitments as of the date of this prospectus to issue any notes or other debt securities, or to otherwise incur outstanding debt following this offering, we may choose to incur substantial debt to complete our initial business combination. The incurrence of debt